Sexual function and depressive symptoms in young women with hypoprolactinaemia.
Robert KrysiakKarolina KowalczeBogusław OkopieńPublished in: Clinical endocrinology (2020)
The obtained results suggest that dopamine agonist-induced hypoprolactinaemia impairs sexual functioning and well-being in young women, as well as that these disturbances are secondary to low prolactin levels, not to specific properties of cabergoline.